Pasar al contenido principal

Marta Villalba Montaner

Instituciones de las que forman parte

Investigador predoctoral
Vall Hebron Institut de Recerca
Marta  Villalba  Montaner

Proyectos

CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY RELATED MALIGNANCIES

IP: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY
Colaboradores: Marta Villalba Montaner, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY, Bárbara Tazón Vega, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY, Silvia Saumell Tutusaus, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY
Entidad financiadora: Instituto de Salud Carlos III
Financiación: 215380
Referencia: PI20/00881
Duración: 01/01/2021 - 31/12/2023

Suscríbete a nuestros boletines y forma parte de la vida del Campus

Vall d'Hebron Barcelona Hospital Campus es un parque de referencia mundial donde la asistencia, la investigación, la docencia y la innovación se dan la mano.